Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ONC
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Titus Benjamin Ball Officer | ONC BeOne Medicines Ltd. | 1,559 | $632.3K | — | Nov 6, 2026 | Form 4 ↗ 4 days later · 1,559 shares | Form 144 ↗ |
| Nov 5, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 1,115 | $421.2K | 10b5-1 | Nov 5, 2026 | Form 4 ↗ 4 days later · 1,115 shares | Form 144 ↗ |
| Sep 30, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 1,115 | $407.3K | 10b5-1 | Sep 30, 2026 | Form 4 ↗ 40 days later · 1,115 shares | Form 144 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director, Chair, Scientific Advisory Brd | ONC BeOne Medicines Ltd. | 131,370 | $47.1M | 10b5-1 | Sep 8, 2026 | Form 4 ↗ 2 days later · 38,287 shares | Form 144 ↗ |
| Sep 1, 2026 | Titus Benjamin Ball Officer | ONC BeOne Medicines Ltd. | 132 | $47.0K | — | Sep 1, 2026 | Form 4 ↗ 2 days later · 132 shares | Form 144 ↗ |
| Aug 25, 2026 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 15,000 | $5.6M | 10b5-1 | Aug 25, 2026 | Form 4 ↗ 2 days later · 280 shares | Form 144 ↗ |
| Aug 25, 2026 | Corazon D. Sanders Former Director | ONC BeOne Medicines Ltd. | 2,075 | $788.5K | — | Aug 25, 2026 | — | Form 144 ↗ |
| Aug 11, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 2,002 | $718.7K | 10b5-1 | Aug 11, 2026 | Form 4 ↗ 2 days later · 2,666 shares | Form 144 ↗ |
| Aug 10, 2026 | John V Oyler Director, Officer | ONC BeOne Medicines Ltd. | 240,810 | $83.9M | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 2 days later · 240,810 shares | Form 144 ↗ |
| Aug 3, 2026 | Aaron Rosenberg Officer | ONC BeOne Medicines Ltd. | 1,157 | $361.8K | — | Aug 3, 2026 | Form 4 ↗ 2 days later · 1,157 shares | Form 144 ↗ |
| Jul 30, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 1,044 | $337.9K | — | Jul 30, 2026 | Form 4 ↗ 4 days later · 1,044 shares | Form 144 ↗ |
| Jul 22, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 2,001 | $637.7K | 10b5-1 | Jul 22, 2026 | Form 4 ↗ 2 days later · 1,669 shares | Form 144 ↗ |
| Jul 14, 2026 | John V Oyler Director, Officer | ONC BeOne Medicines Ltd. | 513,574 | $156.1M | 10b5-1 | Jul 14, 2026 | Form 4 ↗ same day · 145,861 shares | Form 144 ↗ |
| Jul 10, 2026 | John V Oyler Director, Officer | ONC BeOne Medicines Ltd. | 150,000 | $45.4M | 10b5-1 | Jul 10, 2026 | Form 4 ↗ 4 days later · 60,218 shares | Form 144 ↗ |
| Jul 10, 2026 | Pan-Oyler Foundation Director, Officer | ONC BeOne Medicines Ltd. | 49,541 | $15.0M | 10b5-1 | Jul 10, 2026 | Form 4 ↗ 4 days later · 60,218 shares | Form 144 ↗ |
| Jun 23, 2026 | Lai Wang Officer | ONC BeOne Medicines Ltd. | 1,068 | $295.6K | — | Jun 23, 2026 | Form 4 ↗ 2 days later · 1,068 shares | Form 144 ↗ |
| Jun 23, 2026 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 1,292 | $356.9K | — | Jun 23, 2026 | Form 4 ↗ 2 days later · 1,292 shares | Form 144 ↗ |
| Jun 23, 2026 | John Oyler Officer, Director | ONC BeOne Medicines Ltd. | 3,410 | $933.6K | — | Jun 23, 2026 | Form 4 ↗ 2 days later · 3,410 shares | Form 144 ↗ |
| Jun 16, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 590 | $156.9K | — | Jun 16, 2026 | Form 4 ↗ 2 days later · 590 shares | Form 144 ↗ |
| Jun 16, 2026 | Lai Wang Officer | ONC BeOne Medicines Ltd. | 1,169 | $310.2K | — | Jun 16, 2026 | Form 4 ↗ 2 days later · 1,169 shares | Form 144 ↗ |
| Jun 16, 2026 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 1,357 | $362.0K | — | Jun 16, 2026 | Form 4 ↗ 2 days later · 1,357 shares | Form 144 ↗ |
| Jun 16, 2026 | John Oyler Officer, Director | ONC BeOne Medicines Ltd. | 3,693 | $980.7K | — | Jun 16, 2026 | Form 4 ↗ 2 days later · 3,693 shares | Form 144 ↗ |
| Jun 15, 2026 | Corazon D. Sanders Director | ONC BeOne Medicines Ltd. | 945 | $250.9K | — | Jun 15, 2026 | — | Form 144 ↗ |
| Jun 11, 2026 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 626 | $163.5K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 626 shares | Form 144 ↗ |
| Jun 11, 2026 | Lai Wang Officer | ONC BeOne Medicines Ltd. | 756 | $197.6K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 756 shares | Form 144 ↗ |
| Jun 11, 2026 | Aaron Rosenberg Officer | ONC BeOne Medicines Ltd. | 631 | $162.6K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 631 shares | Form 144 ↗ |
| Jun 11, 2026 | Titus Benjamin Ball Officer | ONC BeOne Medicines Ltd. | 169 | $43.5K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 169 shares | Form 144 ↗ |
| Jun 11, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 428 | $110.3K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 428 shares | Form 144 ↗ |
| Jun 11, 2026 | John Oyler Officer, Director | ONC BeOne Medicines Ltd. | 1,949 | $501.4K | — | Jun 11, 2026 | Form 4 ↗ 4 days later · 1,949 shares | Form 144 ↗ |
| Jun 8, 2026 | Titus Benjamin Ball Officer | ONC BeOne Medicines Ltd. | 136 | $36.9K | — | Jun 8, 2026 | Form 4 ↗ 2 days later · 136 shares | Form 144 ↗ |
| Jun 8, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 871 | $235.5K | — | Jun 8, 2026 | Form 4 ↗ 2 days later · 871 shares | Form 144 ↗ |
| Jun 8, 2026 | Lai Wang Officer | ONC BeOne Medicines Ltd. | 1,367 | $368.2K | — | Jun 8, 2026 | Form 4 ↗ 2 days later · 1,367 shares | Form 144 ↗ |
| Jun 8, 2026 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 1,484 | $399.7K | — | Jun 8, 2026 | Form 4 ↗ 2 days later · 1,484 shares | Form 144 ↗ |
| Jun 8, 2026 | John Oyler Officer, Director | ONC BeOne Medicines Ltd. | 4,940 | $1.3M | — | Jun 8, 2026 | Form 4 ↗ 2 days later · 4,940 shares | Form 144 ↗ |
| Jun 1, 2026 | Qingqing Yi Director | ONC BeOne Medicines Ltd. | 235 | $65.6K | — | Jun 1, 2026 | Form 4 ↗ 2 days later · 235 shares | Form 144 ↗ |
| May 22, 2026 | Michael Goller Director | ONC BeOne Medicines Ltd. | 211 | $65.4K | — | May 22, 2026 | — | Form 144 ↗ |
| May 22, 2026 | Ranjeev Krishana Director | ONC BeOne Medicines Ltd. | 212 | $65.6K | — | May 22, 2026 | — | Form 144 ↗ |
| May 22, 2026 | Alessandro Riva Director | ONC BeOne Medicines Ltd. | 212 | $65.6K | — | May 22, 2026 | Form 4 ↗ 5 days later · 212 shares | Form 144 ↗ |
| May 22, 2026 | Margaret Dugan Director | ONC BeOne Medicines Ltd. | 212 | $65.6K | — | May 22, 2026 | Form 4 ↗ 5 days later · 212 shares | Form 144 ↗ |
| May 22, 2026 | Corazon D. Sanders Director | ONC BeOne Medicines Ltd. | 212 | $65.6K | — | May 22, 2026 | Form 4 ↗ 5 days later · 212 shares | Form 144 ↗ |
| May 13, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 1,328 | $418.4K | 10b5-1 | May 13, 2026 | Form 4 ↗ 2 days later · 332 shares | Form 144 ↗ |
| Feb 4, 2026 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 4,676 | $1.6M | 10b5-1 | Feb 4, 2026 | Form 4 ↗ 2 days later · 1,660 shares | Form 144 ↗ |
| Dec 15, 2025 | John V Oyler Director, Officer | ONC BeOne Medicines Ltd. | 100,000 | $31.9M | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| Nov 26, 2025 | Corazon D. Sanders Director | ONC BeOne Medicines Ltd. | 2,627 | $895.5K | — | Nov 26, 2025 | Form 4 ↗ 5 days later · 2,627 shares | Form 144 ↗ |
| Nov 17, 2025 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 3,991 | $1.5M | — | Nov 17, 2025 | Form 4 ↗ 2 days later · 3,991 shares | Form 144 ↗ |
| Nov 13, 2025 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 6,009 | $2.3M | — | Nov 13, 2025 | Form 4 ↗ 1 day later · 16,009 shares | Form 144 ↗ |
| Nov 12, 2025 | Xiaobin Wu Officer | ONC BeOne Medicines Ltd. | 10,000 | $3.6M | — | Nov 12, 2025 | Form 4 ↗ 2 days later · 16,009 shares | Form 144 ↗ |
| Oct 8, 2025 | Chan Lee Officer | ONC BeOne Medicines Ltd. | 13,659 | $4.7M | 10b5-1 | Oct 8, 2025 | Form 4 ↗ 2 days later · 10,671 shares | Form 144 ↗ |
| Sep 16, 2025 | Pan-Oyler Foundation Director, Officer | ONC BeOne Medicines Ltd. | 1,204 | $400.1K | 10b5-1 | Sep 16, 2025 | Form 4 ↗ 2 days later · 27,803 shares | Form 144 ↗ |
| Sep 16, 2025 | John V Oyler Director, Officer | ONC BeOne Medicines Ltd. | 27,803 | $9.2M | 10b5-1 | Sep 16, 2025 | Form 4 ↗ 2 days later · 27,803 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances